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Background
The immune microenvironment is important to the
pathophysiology of head and neck squamous cell carci-
noma (HNSCC). Our aim was to investigate the prognos-
tic significance of tumour-infiltrating lymphocytes (TILs)
in operable tongue cancer patients treated with curative
surgery and adjuvant radiotherapy with or without
chemotherapy.
Patients and methods
The presence of CD3+, CD4+, CD8+ and FOXP3+ TILs
in tumor tissues obtained from 93 patients during surgery
were examined by immunohistochemistry. Correlation
between clinicopathological features and TILs was investi-
gated. The prognostic roles of TILs for local recurrence-
free survival (LRFS), regional recurrence-free survival
(RRFS), distant metastasis-free survival (DMFS) and over-
all survival (OS) were analyzed.
Results
Median follow up time was 31.4 months (range, 0.2-
99.8 months). Higher number of CD4+ cells (p = 0.006),
higher CD4/FOXP3 ratio (p = 0.012), lower CD3/CD4
ratio (p = 0.043), and higher CD4/CD8 ratio (p = 0.006)
were correlated with the absence of lymphovascularinva-
sion (LVI). Patients with lower FOXP3+ TILs and higher
CD8/FOXP3 ratio had marginally better RRFS (p = 0.071,
and p = 0.069, respectively) (Figure 1 and Figure 2.).
Patients with higher CD4/CD3 ratio had a significantly
better DMFS (p = 0.036) (Figure 3).
Conclusion
CD4+ TILs and its ratio to other TILs were inversely
correlated with LVI. Higher CD4/CD3 ratio predicts
better DMFS. Prognostic role of FOXP3 in RRFS
was marginally significant and warrants further
investigation.
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Figure 1 Regional recurrence-free survival (RRFS) according to
FOXP3+ TILs.
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Figure 2 RRFS according to CD8/FOXP3 ratio. Figure 3 Distant metastasis-free survival (DMFS) according to
CD4/CD3 ratio.
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